Northern Trust
SLGC

Northern Trust’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Northern Trust’s Portfolio SLGC Stock Details SLGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,556,647
Closed -$3.94M – 4550
2023
Q4 		$3.94M Buy
1,556,647
+68,714
+5% +$160K ﹤0.01% 2641
2023
Q3 		$3.56M Buy
1,487,933
+119
+0% +$263 ﹤0.01% 2636
2023
Q2 		$3.44M Buy
1,487,814
+134,090
+10% +$379K ﹤0.01% 2707
2023
Q1 		$3.45M Buy
1,353,724
+16,960
+1% +$48.6K ﹤0.01% 2673
2022
Q4 		$3.36M Buy
1,336,764
+35,348
+3% +$98.6K ﹤0.01% 2714
2022
Q3 		$3.77M Sell
1,301,416
-22,877
-2% -$96.3K ﹤0.01% 2656
2022
Q2 		$5.99M Buy
1,324,293
+1,079,888
+442% +$6.43M ﹤0.01% 2392
2022
Q1 		$1.96M Sell
244,405
-4,190
-2% -$37K ﹤0.01% 3115
2021
Q4 		$2.89M Buy
+248,595
New +$2.98M ﹤0.01% 3027

Northern Trust's SLGC Position: Q1 2024 in Review

Northern Trust sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 1,556,647 shares — an estimated $3.94M sold.

Northern Trust first reported a position in SLGC in Q4 2021 and held it in 9 quarters. The position peaked at $5.99M in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Northern Trust reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Northern Trust sold 1,556,647 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $3.94M.
  • Northern Trust first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 9 quarters.
  • Northern Trust's SomaLogic, Inc. Class A Common Stock position peaked at $5.99M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.